RISE Life Science Corp. announced earnings results for the third quarter ended August 31, 2019. For the third quarter, the company announced net loss was CAD 2.242 million compared to CAD 2.277 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.04 a year ago. For the nine months, net loss was CAD 5.789 million compared to CAD 4.037 million a year ago. Basic loss per share from continuing operations was CAD 0.1 compared to CAD 0.12 a year ago.